DrugBiological

Efineptakin alfa clinical trials

Also written NT-I7 and TJ107.

studies test it: 29
open now: 1
in phase 3: 0
first study started: 2016

Keep track of what changes. Save the efineptakin alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

29 studies that test it; most in 2021 (8)

Studies that test efineptakin alfa, by start year
Year	Studies
2016	1
2017	2
2018	4
2019	4
2020	4
2021	8
2022	3
2023	2
2026	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 20
Phase 2: 12
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Glioblastoma: 5
COVID-19: 4
Squamous Cell Carcinoma of Head and Neck: 3
Glioma: 2
Neoplasms: 2
Lymphoma, Large B-Cell, Diffuse: 1
Triple Negative Breast Neoplasms: 1
Leukoencephalopathy, Progressive Multifocal: 1
Multiple Myeloma: 1
Carcinoma, Non-Small-Cell Lung: 1
Melanoma: 1
Adenocarcinoma: 1

Who runs them

Industry 18 · Other 11

Genexine, Inc. (8) · NeoImmuneTech (6) · Washington University School of Medicine (3) · TJ Biopharma Co., Ltd. (3) · Mayo Clinic (1) · Yonsei University (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Hyunseok Kang, MD (1)

Often tested with

Tested in the same studies.

Pembrolizumab (4) · Gosha-jinki-gan (3) · HPV E6/E7 DNA Vaccine GX-188E (2) · Atezolizumab (2) · Bevacizumab (1) · Tisagenlecleucel (1) · Axicabtagene ciloleucel (1) · Lisocabtagene maraleucel (1)

Studies

Open first, then newest update. How each study uses efineptakin alfa is read from its arms, and is right about nine times in ten.

Testing it · 29

See all 29 studies that test efineptakin alfa →

Given in every arm · 2 — efineptakin alfa is usual care beside what is tested

Codes

What other systems call efineptakin alfa · ClinicalTrials.gg INT001518

MeSH (NLM) C000712767efineptakin alfaConfirmed ClinicalTrials.gov, NLM
UNII (FDA) 3K3WC6MT6PEFINEPTAKIN ALFAConfirmed FDA, NLM
NCI Thesaurus C151927Efineptakin alfaOne source FDA

System	Code	Name there	Checked by
MeSH (NLM)	C000712767	efineptakin alfa	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	3K3WC6MT6P	EFINEPTAKIN ALFA	Confirmed FDA, NLM
NCI Thesaurus	C151927	Efineptakin alfa	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.